These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 9115955)

  • 1. Medical treatment of end-stage heart failure.
    Binetti G; Senni M; Colombo F; Tasca G; Mamprin F; Caporale R; Ferrazzi P; Gamba A; Glauber M; Troise G; Fiocchi R
    Cardiovasc Drugs Ther; 1996 Nov; 10 Suppl 2():617-22. PubMed ID: 9115955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Digitalis, diuretic and vasodilator treatment of cardiac failure].
    Juillière Y
    Rev Prat; 1997 Dec; 47(19):2125-9. PubMed ID: 9501604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical advances in the treatment of congestive heart failure.
    Armstrong PW; Moe GW
    Circulation; 1993 Dec; 88(6):2941-52. PubMed ID: 7902784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy for heart failure].
    Just H
    Ther Umsch; 2000 May; 57(5):313-20. PubMed ID: 10859991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of dilated cardiomyopathy with digitalis, diuretics and vasodilators].
    Liebau G
    Herz; 1985 Jun; 10(3):138-42. PubMed ID: 2991095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of heart failure. Digitalis, diuretic plus ACE inhibitor or more?].
    Becker H; Sigmund M
    Internist (Berl); 1995 Dec; 36(12):1117-23. PubMed ID: 8567216
    [No Abstract]   [Full Text] [Related]  

  • 7. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing the treatment of heart failure.
    Giles TD
    Curr Opin Cardiol; 1994 Jul; 9 Suppl 1():S21-7. PubMed ID: 7827370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination drug therapy in chronic heart failure: is treatment part of the problem in heart failure?
    Cleland JG
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():297-303. PubMed ID: 9211024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the treatment of congestive heart failure: diuretics, vasodilators, and angiotensin-converting enzyme inhibitors.
    Chow MS
    Pharmacotherapy; 1993; 13(5 Pt 2):82S-87S. PubMed ID: 8233997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacoeconomic considerations in assessing and selecting congestive heart failure therapies.
    Levy E; Levy P
    Pharmacoeconomics; 2002; 20(14):963-77. PubMed ID: 12403637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary medical management of left ventricular dysfunction and congestive heart failure.
    Teo KK; Ignaszewski AP; Gutierrez R; Hill KL; Martin SL; Calhoun HP; Humen DP; Montague TJ
    Can J Cardiol; 1992; 8(6):611-9. PubMed ID: 1354569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New trends in the use of angiotensin converting enzyme inhibitors in chronic heart failure.
    Massie BM
    Am J Med; 1988 Apr; 84(4A):36-46. PubMed ID: 3064607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Refractory heart failure: it requires the use of polychemotherapy. What is the rationale?].
    Campa PP; Puddu PE; Schiariti M; Monti F; Dawodu AA; Gentile C; Lilla Della Monica PL; Vaccaro M; De Biase L
    Cardiologia; 1995 Dec; 40(12 Suppl 1):139-50. PubMed ID: 8998706
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug therapy of cardiac insufficiency: status 1995].
    Rickenbacher P; Buser P; Osswald S; Pfisterer M
    Schweiz Med Wochenschr; 1996 May; 126(21):933-45. PubMed ID: 8693314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
    Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
    Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New knowledge on the subject of therapy in cardiac decompensation in the light of large trials].
    Camerini F; Perkan A; Sinagra G; Di Lenarda A; Pinamonti B; Zecchin M
    Ann Ital Med Int; 1994 Oct; 9 Suppl():68S-77S. PubMed ID: 7857761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of heart failure--an overview.
    Erdmann E
    Basic Res Cardiol; 2000; 95 Suppl 1():I3-7. PubMed ID: 11192349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic heart failure: improvement of the prognosis by therapy?].
    Drexler H
    Herz; 1990 Jun; 15(3):214-21. PubMed ID: 1973916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.